Phase 2 Gene Therapy Trial of an Anti-HIV Ribozyme in Autologous CD34+ Cells. Nature, 15: 285-292.

In by AHF

Analysis of a Switch From Enfuvirtide to Raltegravir in Patients with Undetectable Viral Load: Efficacy and Quality of Life at 24 Weeks. Journal of the International Association of Physicians in AIDS Care, 8(2): 85-86.
The Use of Darunavir/Ritonavir as Intensification in Low Viremic HIV-Infected Patients Treated with Boosted Protease Inhibitor-Containing Regimens. Journal of the International Association of Physicians in AIDS Care, 8(1): 21-22.
Download
File Type: 1932
Categories: 2009
Tags: 1999-2009